Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer.
Gao J, Zhang X, Yang Z, Zhang J, Bai Z, Deng W, Chen G, Xu R, Wei Q, Liu Y, Han J, Li A, Liu G, Sun Y, Kong D, Yao H, Zhang Z.
Gao J, et al. Among authors: liu y, liu g.
Front Oncol. 2023 Feb 2;13:1057947. doi: 10.3389/fonc.2023.1057947. eCollection 2023.
Front Oncol. 2023.
PMID: 36816939
Free PMC article.